Records containing: Multiple Myeloma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-07-20Hemato-Oncology Latin America Observational Registry in CLL, Multiple Myeloma, Non-Hodgkin Lymphoma
-
CLINICAL_TRIALS study record update · 2016-07-18Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic Disorders
-
CLINICAL_TRIALS study record update · 2016-07-12Allogeneic Stem Cell Transplantation for Patients With Multiple Myeloma: a Pilot Feasibility Study Using a Novel Protocol
-
CLINICAL_TRIALS study record update · 2016-07-11Pharmacokinetic Study of Bortezomib (VELCADE) Administered Intravenously in Taiwanese Patients With Multiple Myeloma - A Post Approval Commitment Study
-
CLINICAL_TRIALS study record update · 2016-07-06A Phase I Study of Bortezomib (VELCADE) in Combination With Pralatrexate in Relapsed/Refractory Multiple Myeloma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-07-04Autologous Followed By Non-Myeloablative Allogeneic Transplant For Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-07-01Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation For Patients With Disease Relapse Or Myelodysplasia After Prior Autologous Transplantation
-
CLINICAL_TRIALS study record update · 2016-06-27Non-Myeloablative Conditioning and Unrelated Umbilical Cord Blood Transplantation for Children and Adults With Serious Oncohematologic Diseases
-
CLINICAL_TRIALS study record update · 2016-06-21Phase II Study of Revlimid®, Oral Cyclophosphamide and Prednisone (RCP) for Patients With Newly Diagnosed Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-06-20An Observational Study of the Treatment of Multiple Myeloma in Routine Clinical Practice
-
CLINICAL_TRIALS study record update · 2016-06-17Assessment of Molecular Remission by ASO-RQ-PCR Technique After Induction Treatment With Bortezomib-dexamethasone (Vel/Dex) Followed by HDT With ASCT
-
CLINICAL_TRIALS study record update · 2016-06-14REal Life, Retrospective Study of BOrtezomib Use as secoND Treatment for Myeloma Patients Previously Exposed to Bortezomib-based Therapies as First Line
-
CLINICAL_TRIALS study record update · 2016-06-14A Safety Confirmation Study On Lenalidomide With Dexamethasone In Japanese Patients With Previously Treated Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-06-06Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool
-
CLINICAL_TRIALS study record update · 2016-06-02A Phase 1/2 Open-label Study to Assess the Safety, Tolerability and Preliminary Efficacy of TH-302, A Hypoxia-Activated Prodrug, and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-05-17Evaluation of a Method Designed to Improve Outcome of HD Chemotherapy and AHSCT for Patients With Myeloma: Total Marrow Irradiation Administered Via Helical Tomotherapy Plus High-Dose Melphalan and Amifostine Before AHSCT2
-
CLINICAL_TRIALS study record update · 2016-05-17ClinicalTrials.gov study NCT01376401
-
CLINICAL_TRIALS study record update · 2016-05-12A Phase II Trial to Determine the Effect of Imetelstat (GRN163L) on Patients With Previously Treated Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-05-11Phase I Study of Sequential Cord Blood Transplants
-
CLINICAL_TRIALS study record update · 2016-05-10Phase III Study of Single Autologous Stem Cell Transplantation Followed by Maintenance Therapy as Front-line Treatment for Myeloma
-
CLINICAL_TRIALS study record update · 2016-05-10A Phase II, Multi-center, Open-label, Randomized Study of Vorinostat Plus Lenalidomide and Dexamethasone or Lenalidomide Plus Dexamethasone in Multiple Myeloma Patients Who Experience Biochemical Relapse During Lenalidomide Maintenance Therapy
-
CLINICAL_TRIALS study record update · 2016-05-10A Phase I/II, Multi-Center, Open Label Study of Melphalan, Prednisone, Thalidomide and Defibrotide in Advanced and Refractory Multiple Myeloma Patients
-
CLINICAL_TRIALS study record update · 2016-05-10Lenalidomide, Melphalan, Prednisone, and Thalidomide (RMPT) for Relapsed/Refractory Multiple Myeloma
-
CLINICAL_TRIALS study record update · 2016-05-06Phase 1 Dose-Escalation and Pharmacokinetic Study of TG02 Citrate in Patients With Advanced Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2016-04-29Pilot Trial of Fractionated Stem Cell Infusions in Myeloma Patients Undergoing Autologous Stem Cell Transplant